PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Free home flu test kits for Flusurvey participants

Scientists from Flusurvey and i-sense call for public to help monitor spread of UK flu more accurately than ever before

Free home flu test kits for Flusurvey participants
2014-11-19
(Press-News.org) People taking part in this year's Flusurvey, the UK's biggest crowd-sourced study of influenza will for the first time be offered a swab to confirm if their symptoms are caused by a flu virus or not as part of a new collaboration with i-sense. Data from social media and internet searches will also be combined with Flusurvey, allowing flu trends to be monitored across the UK more accurately and earlier than ever before.

Flusurvey scientists at the London School of Hygiene & Tropical Medicine will analyse weekly information relating to symptoms, provided in an online questionnaire by participants, to monitor if flu is taking hold over the winter months.

They will team up with Public Health England (PHE) and i-sense, an £11M EPSRC funded interdisciplinary research collaboration led by UCL to develop early warning sensing systems for infectious disease, to compare this information with the results of swab samples and with 'big data' on millions of symptoms reported every day via sources such as Twitter.

Complaints of coughs, colds and flu-like symptoms are a common feature of life at this time of year but not all sniffles are a sign of flu. Verifying cases of a virus through testing is a crucial part of efforts to spot a pandemic flu outbreak with the potential to cause serious illness and death, and Flusurvey data feeds into national surveillance programmes.

This year, some participants who sign up at http://www.flusurvey.org.uk will provide a self-administered nasal swab, enabling official confirmation and a more accurate picture of flu trends in the UK.

Swabs will be sent to 700 participants of different ages and in different locations, selected to represent the population as a whole. If they report an influenza-like illness in their weekly Flusurvey update, they will use the swab themselves at home and see the results in a matter of minutes - much like a home pregnancy test. They will submit their results via email as well as posting the test to a PHE laboratory for verification.

The number of positive tests received each week will be compared to figures obtained by GP-based virological sampling run by PHE for the same week.

UK Flusurvey's coordinator, Clare Wenham, Research Fellow in Public Health Engagement at the London School of Hygiene & Tropical Medicine, said: "Virological swabbing is an exciting development of the Flusurvey project as it is going to allow us to see whether those who report symptoms online actually are suffering from a flu virus or something else entirely. This way we can get a much better understanding of the burden of flu at any one time in the UK.

"The ability to rapidly detect a novel strain of influenza is often hampered as most cases do not present at primary care, and the symptoms associated with flu are shared by many diseases. Piloting a system of detecting influenza in the community by self-administered swabbing, linked to an existing internet-based cohort, should enable rapid detection of influenza in the future."

Professor Rachel McKendry, Director of i-sense at UCL, added: "This exciting project will identify flu outbreaks much earlier than ever before and help us to develop a new generation of mobile phone-connected tests allowing people to report their symptoms and self-test in their own homes. Throughout this flu season, i-sense researchers at UCL will be using this data to develop a mobile app which will provide up to the minute information about flu hotspots. In future, mobile phone connected tests could also help patients gain more rapid access to follow up care."

The annual UK Flusurvey, now in its sixth year, collects data from men, women and children of all ages around the country. This is used to map trends as seasonal flu takes hold, enabling researchers to analyse how a virus spreads and who it may affect. The data is supplied weekly to PHE's national flu surveillance programmes. Anyone can take part in Flusurvey at http://www.flusurvey.org.uk and it only takes a couple of minutes each week.

New findings released today from last year's survey reveal that every person suffering from a flu-like illness loses the equivalent of two days of healthy life.1 More than 5,000 people took part in the UK Flusurvey last year.

In previous years, Flusurvey data has revealed that doing vigorous exercise for at least 2.5 hours a week reduces your chances of experiencing a flu-like illness by around 10%, dispelled the myth that taking public transport makes you more likely to get flu, and shown that "man flu" does not really exist.

Researchers are calling for members of the public across the UK to sign up to participate in order to collect as much data as possible to map this year's flu trends and to help medics and health services prepare. Traditional monitoring methods rely on data from GPs or hospitals, but Flusurvey provides a unique insight because many people with flu-like illness do not visit a doctor.

Flusurvey is linked with comparable surveys in 10 European countries: France, Italy, Spain, Portugal, Ireland, Sweden, Denmark, Belgium, the Netherlands and the United Kingdom. Online maps make it possible to track the spread of seasonal flu across the continent.

INFORMATION:

The research is funded by an EPSRC i-sense Exploratory Project grant.

For more information or to request interviews, please contact the London School of Hygiene & Tropical Medicine press office: 020 7927 2802 or press@lshtm.ac.uk.

Notes to Editors:

1 Although most people recover from flu, it can make people feel very unwell and reduce their quality of life while they are ill. By combining this information with the length of illness reported, the Flusurvey researchers say that having flu is equivalent to losing 2 days of healthy life. Full data available at http://www.flusurvey.org.uk/en/results

Photos available for download of Clare Wenham using the swab kit and swab kit close-up. Please credit London School of Hygiene & Tropical Medicine: http://track.vuelio.uk.com/z.z?l=aHR0cDovL2xzaHRtYWMuaW1hZ2VzLnZ1ZWxpby51ay5jb20vcGlja3VwcGljdHVyZXMudGx4P3BrcHBpZD02NzY0OTI%3d&r=4502315916&d=1024613&p=1&t=h&h=f232473e9eeeda3be1111deec36161f0 Get in touch with Flusurvey on Twitter @flusurvey and Facebook.

About the London School of Hygiene & Tropical Medicine The London School of Hygiene & Tropical Medicine is a world-leading centre for research and postgraduate education in public and global health, with 3,900 students and more than 1,000 staff working in over 100 countries. The School is one of the highest-rated research institutions in the UK, and was recently cited as the world's leading research-focused graduate school. Our mission is to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice. http://www.lshtm.ac.uk Get in touch on Twitter @lshtmpress

About i-sense i-sense is a 5 year Interdisciplinary Research Collaboration in Early Warning Sensing Systems for Infectious Diseases, funded by the Engineering and Physical Sciences Research Council (EPSRC). We aim to detect outbreaks of serious infections - including new strains of influenza, MRSA and HIV - much earlier than ever before by linking self-reported symptoms on social media and search engines with a new generation of mobile phone-connected diagnostic tests. The programme brings together an interdisciplinary team of researchers from UCL, Imperial College, London School for Hygiene and Tropical Medicine, Newcastle and Surrey universities, clinicians at UCL Partners, UCLH BRC, Newcastle BRC, Public Health England and industry. For more information about our research and funding opportunities, please visit http://www.i-sense.org.uk or contact i-sense Administration and Communications Manager, Kailey Nolan at k.nolan@ucl.ac.uk. Follow us on Twitter @isenseIRC

About UCL (University College London) Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. We are among the world's top universities, as reflected by performance in a range of international rankings and tables. UCL currently has almost 29,000 students from 150 countries and in the region of 10,000 employees. Our annual income is more than £900 million. http://www.ucl.ac.uk | Follow us on Twitter @uclnews | Watch our YouTube channel YouTube.com/UCLTV


[Attachments] See images for this press release:
Free home flu test kits for Flusurvey participants Free home flu test kits for Flusurvey participants 2

ELSE PRESS RELEASES FROM THIS DATE:

Do wearable baby monitors offer parents real peace of mind?

2014-11-19
David King, clinical lecturer in paediatrics at the University of Sheffield, says medical professionals and consumers need to be aware that such devices "have no proved use in safeguarding infants or detecting health problems, and they certainly have no role in preventing [sudden infant death syndrome] SIDS." Wearable devices for infants are a growing industry worldwide. Devices that attach to a newborn baby to monitor its vital signs are marketed by several US companies at a cost of around $200 to $300 to give parents "peace of mind" about their baby's health. One ...

Stressful duties linked with increased risk of sudden cardiac death among police officers

2014-11-19
The authors say their findings are applicable to law enforcement work outside the US and support the view that stressful work related activities can "trigger" sudden cardiac death.   Law enforcement is a dangerous occupation. In 2011-2012, the fatality rate among US patrol officers was 15-16 per 100,000 full time workers - about 3-5 times the national average for private sector employees.   Some evidence suggests that cardiovascular disease is higher among police officers than the general population, but data about the impact of specific on duty activities ...

Genetically low vitamin D associated with increased mortality

2014-11-19
Observational studies have suggested that lower levels of vitamin D are associated with increased mortality, but whether low vitamin D concentrations are a cause of increased mortality or simply a consequence of poor health is thus unclear. This is an important question, say the authors, as millions of people worldwide are regularly taking vitamin D supplements, presumably with the aim of preventing diseases and hopefully living longer. Genetic variants have been reliably associated with circulating concentrations of vitamin D, a marker of vitamin D status. So a research ...

Police face higher risk of sudden cardiac death during stressful duties

2014-11-19
Boston, MA -- Police officers in the United States face roughly 30 to 70 times higher risk of sudden cardiac death (SCD) when they're involved in stressful situations--suspect restraints, altercations, or chases--than when they're involved in routine or non-emergency activities, according to a new study from Harvard School of Public Health (HSPH) and Cambridge Health Alliance (CHA). It is the first study to provide data that demonstrates the impact of stressful duties on on-duty SCD. The researchers also found that physical training activities--which police don't consider ...

Paradox lost: Speedier heart attack treatment saves more lives after all, study suggests

Paradox lost: Speedier heart attack treatment saves more lives after all, study suggests
2014-11-19
ANN ARBOR, Mich. -- A national effort to shave minutes off emergency heart attack treatment time has increased the chance that each patient will survive, a new study suggests. But yet the survival rate for all patients put together hasn't budged. It seems like a paradox. But wait, say the authors of the new report: the paradox vanishes with more detailed analysis of exactly who has been getting this treatment. Far more people are getting emergency angioplasty and stents for heart attacks now than before. That number now includes more people with more complicated health ...

First demonstration of anti-cancer activity for an IDH1 mutation inhibitor

2014-11-19
Barcelona, Spain: A phase I trial of the first drug designed to inhibit the cancer-causing activity of a mutated enzyme known as isocitrate dehydrogenase (IDH) 1, which is involved in cell metabolism, has shown clinical activity in patients with advanced acute myeloid leukaemia (AML) with the IDH1 mutation. Professor Daniel Pollyea, M.D. will tell the 26th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, today (Wednesday) that early results from the phase 1 clinical trial of the drug AG-120, an oral, selective and potent inhibitor ...

Kidney cancer patients respond well to a combination of 2 existing anti-cancer drugs

2014-11-19
Barcelona, Spain: Researchers have found that patients with an advanced form of kidney cancer, for which there is no standard treatment and a very poor prognosis, respond well to a combination of two existing anti-cancer drugs. Dr Ramaprasad Srinivasan, head of the Molecular Cancer Therapeutics Section, Urologic Oncology Branch, of the National Cancer Institute in Maryland, USA, will tell the 26th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, today (Wednesday) that the combination of bevacizumab and erlotinib produced ...

Galeterone shows activity in a variant form of castration-resistant prostate cancer

2014-11-19
Barcelona, Spain: Results from a trial of the anti-cancer drug galeterone show that it is successful in lowering prostate-specific antigen (PSA) levels in men with a form of prostate cancer that is resistant to treatment with hormone therapy (castration-resistant prostate cancer or CRPC). Associate professor Mary-Ellen Taplin, of the Dana-Farber Cancer Institute, Boston, USA, will tell the 26th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, today (Wednesday) that galeterone was well tolerated by patients in the ARMOR2 trial, ...

Low vitamin D levels increase mortality

Low vitamin D levels increase mortality
2014-11-19
VIDEO: New research from the University of Copenhagen and Copenhagen University Hospital shows that low blood vitamin D levels increase mortality. The study included 96,000 Danes and was recently published in... Click here for more information. Vitamin D deficiency is generally associated with an increased risk of poor bone health. However, recent studies have shown that low levels of this important vitamin also involve an increased risk of other diseases and higher mortality ...

The Lancet Psychiatry: Coping strategies therapy significantly improves dementia carers' mental health and quality of life

2014-11-19
A brief coping strategies therapy which provides stress relief and emotional support for people caring for relatives with dementia can reduce depression and anxiety and improve wellbeing at no extra cost to standard care, new research published in The Lancet Psychiatry suggests. The study led by Gill Livingston, Professor of Psychiatry of Older People at University College London in the UK, found that family caregivers receiving the START (STrAtegies for RelaTives) programme were seven times less likely to develop clinically significant depression than those given usual ...

LAST 30 PRESS RELEASES:

Andrew Siemion to receive the SETI Institute’s 2024 Drake Award

New study shows how the Crimean-Congo hemorrhagic fever virus enters our cells

Neoadjuvant chemotherapy proves effective for locally advanced penile squamous cell carcinoma

Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes

Doctors received approximately $12.1 billion from drug and device makers between 2013-2022

Discovery suggests new strategy against follicular lymphoma

Making the future too bright: how wishful thinking can point us in the wrong direction

Ochsner Health named to Newsweek’s America’s Greatest Workplaces 2024 for Job Starters

Three-year study of young stars with NASA’s Hubble enters new chapter

North Carolina takes the lead in PFAs research with Collaboratory’s $3 million investment to expand the state’s research capacity

Is it the school, or the students?

Exploring the relationship between HIV pre-exposure prophylaxis and the incidence of chlamydia, gonorrhea and syphilis – findings from Denmark

Music: Song lyrics have become simpler and more repetitive since 1980

Environment: More than half of Colorado River’s water used to irrigate crops

When inequality is more than “skin-deep”: Social status leaves traces in the epigenome of spotted hyenas in Tanzania

Study explores the future of at-home cancer treatment

First performance standards published to measure the effectiveness of lifestyle medicine treatments

To keep volunteers, connect them

Suppressing boredom at work hurts future productivity, study shows

Older brain cells linger unexpectedly before their death

Clear shift in arterial diseases in diabetes

Celebrating half a century of pioneering excellence: EBMT marks its 50th anniversary

Ancient DNA reveals the appearance of a 6th century Chinese emperor

DNA study IDs descendants of George Washington from unmarked remains, findings to aid service member IDs going back to World War II

Familial Alzheimer’s disease transferred via bone marrow transplant in mice

Perspectives of oncologists on the ethical implications of using AI for cancer care

Industry payments to US physicians by specialty and product type

Andrew E. Place, MD, PhD appointed as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Vice President, Pediatric Chief Medical Officer

COVID-19 antibody discovery could explain long COVID

Wild plants face viral surprise

[Press-News.org] Free home flu test kits for Flusurvey participants
Scientists from Flusurvey and i-sense call for public to help monitor spread of UK flu more accurately than ever before